Advanced search

Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step towards personalized therapy

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Soenen, Rani, Evelyn Meulewaeter, Lynda Grine, Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert, Sven Lanssens, Linda Termmerman, Jo Lambert, and Ann Gils. 2019. “Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis : a Step Towards Personalized Therapy.” Journal of Investigative Dermatology.
APA
Soenen, R., Meulewaeter, E., Grine, L., Van den Berghe, N., Brouwers, E., Speeckaert, R., Lanssens, S., et al. (2019). Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step towards personalized therapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY.
Vancouver
1.
Soenen R, Meulewaeter E, Grine L, Van den Berghe N, Brouwers E, Speeckaert R, et al. Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step towards personalized therapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2019;
MLA
Soenen, Rani et al. “Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis : a Step Towards Personalized Therapy.” JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019): n. pag. Print.
@article{8617728,
  author       = {Soenen, Rani and Meulewaeter, Evelyn and Grine, Lynda and Van den Berghe, Nathalie and Brouwers, Els and Speeckaert, Reinhart and Lanssens, Sven and Termmerman, Linda and Lambert, Jo and Gils, Ann},
  issn         = {0022-202X},
  journal      = {JOURNAL OF INVESTIGATIVE DERMATOLOGY},
  language     = {eng},
  title        = {Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step towards personalized therapy},
  url          = {http://dx.doi.org/10.1016/j.jid.2019.04.012},
  year         = {2019},
}

Altmetric
View in Altmetric